CYP cynata therapeutics limited

That which can't be done with 2D would not be able to be done...

  1. 2,282 Posts.
    lightbulb Created with Sketch. 1205
    That which can't be done with 2D would not be able to be done with 3D.

    For small scale manufacturing 2D may be sufficient but the skilled labor handling is something that if you could go to 3D would give very significant cost savings.

    "uniform, consistent and infinitely expandable without facing the issues of cell senescence."

    Don't have time to do this right now, but nothing much is infinitely expandable - that sounds like Ross speak - iPSCs shouldn't senescence (run into the Hayflick limit as a result of shortening telomeres and perhaps other factors) but Ross has done nobody any favors by pretending that the costs of manufacturer are mostly resolved by 2D - that simply cannot be so - its like comparing working with a shovel to working a bull dozer - the costs of doing a bigger job require understanding all the costs in the production process.

    Ross, and shareholders swallowing Ross simplifications have keep shareholders substantially ignorant. In the end shareholder ignorance is on the shareholders themselves.


    There are different types of 3D.

    Last edited by JB1975: 31/07/23
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.0¢
Change
0.000(0.00%)
Mkt cap ! $36.15M
Open High Low Value Volume
16.0¢ 16.0¢ 16.0¢ $1.021K 6.379K

Buyers (Bids)

No. Vol. Price($)
4 77738 16.0¢
 

Sellers (Offers)

Price($) Vol. No.
16.5¢ 3400 1
View Market Depth
Last trade - 09.59am 24/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.